University of Alabama at Birmingham Cancer Center — Birmingham, Alabama

Public research footprint of University of Alabama at Birmingham Cancer Center, compiled from the ClinicalTrials.gov public registry.

353

Registered studies

183

Active

Recruiting now

140

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Endometrial Carcinoma · Myelodysplastic Syndrome · Endometrial Clear Cell Adenocarcinoma · Metastatic Non-Cutaneous Melanoma

Recently updated registry entries

NCT02196181 — Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer… (Active Not Recruiting)
NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)
NCT04671667 — Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Alabama at Birmingham Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.